T cell receptor alpha variable 12-3 (TRAV12-3)

T cell receptor alpha variable 12-3 (TRAV12-3) encodes the variable region of the alpha chain in the T cell receptor (TCR) complex, a membrane-bound heterodimeric receptor essential for antigen-specific T cell immune responses[1][4]. The TCR specifically recognizes peptide fragments bound to major histocompatibility complex (MHC) molecules on antigen presenting cells, initiating T cell signaling cascades required for adaptive immunity, including activation, growth, and differentiation of T lymphocytes[1][4]. The TRAV12-3 gene is one of numerous variable (V) region segments that contribute to TCR diversity through somatic recombination, enabling a broad range of antigen recognition[1]. While variants like TRAV12-3 are not typically therapeutic targets by themselves, the TCR as a whole is fundamental to immunotherapy approaches, immune monitoring, and biomarker research in oncology, infection, and inflammatory diseases[1][4][3]. If more specifically structured drug, biomarker, or safety data become available for TRAV12-3 in the future, such entries would be more precisely populated.

Other names

TRAV12-3TRAV123TCRAV2S2TCRAV12S3TVAL3

TCR agonists/antagonists: Modify T cell activation by stimulating or blocking TCR-pMHC interaction; Immunosuppressants (e.g., cyclosporine, tacrolimus): Inhibit downstream TCR signaling by targeting calcineurin pathway; Biologics (e.g., engineered TCRs): Redirect T cell specificity against disease antigens (primarily in research and experimental therapies)